Dharmesh Dingar
About Dharmesh Dingar
Dharmesh Dingar is a Senior Scientist at Sana Biotechnology, Inc. in Cambridge, Massachusetts, with extensive experience in biosimilar and biologics drug development and expertise in assay development and validation.
Work at Sana Biotechnology
Dharmesh Dingar has been serving as a Senior Scientist at Sana Biotechnology, Inc. since 2021. His role is based in Cambridge, Massachusetts, where he has been involved in the management of scientific research projects. His expertise contributes to the company's focus on developing innovative therapies through advanced biotechnology.
Previous Experience in Bioanalytics
Before joining Sana Biotechnology, Dharmesh Dingar worked at Apobiologix as a Scientist in Bioanalytics from 2017 to 2019. In this position, he focused on developing and validating assays related to pharmacokinetics (PK), pharmacodynamics (PD), biomarkers, and immunogenicity. His work in this area contributed to the advancement of drug development processes.
Career at Novum Pharmaceutical Research Services
Dharmesh Dingar held the position of Senior Scientist at Novum Pharmaceutical Research Services from 2019 to 2021. His responsibilities included overseeing scientific projects and ensuring compliance with regulatory requirements. His experience in this role further solidified his expertise in the field of biologics and biosimilar drug development.
Education and Expertise
Dharmesh Dingar earned his PhD in Biochemistry from Université de Montréal, where he studied from 2006 to 2011. His academic background laid the foundation for his extensive knowledge of FDA, EMA, and Health Canada requirements for laboratory work. This education has been instrumental in his career in the biotechnology sector.
Research Background at Montreal Heart Institute
Prior to his industry experience, Dharmesh Dingar was a PhD candidate at the Montreal Heart Institute from 2006 to 2010. During this time, he engaged in research that contributed to his understanding of cardiovascular health and disease, further enhancing his qualifications in scientific research and drug development.